Gainers
- Immix Biopharma, Inc. IMMX rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
- Missfresh Limited MF rose 27.3% to $0.3118 in pre-market trading after gaining over 51% on Wednesday.
- Chewy, Inc. CHWY rose 17.5% to $27.60 in pre-market trading after the company reported better-than-expected Q1 sales results.
- Repare Therapeutics Inc. RPTX rose 17.1% to $10.25 in pre-market trading. Repare Therapeutics entered into a collaboration and license agreement with Hoffmann-La Roche and F. Hoffmann-la Roche.
- Selecta Biosciences, Inc. SELB shares rose 15.2% to $0.97 in pre-market trading after declining around 5% on Wednesday.
- Blue Apron Holdings, Inc. APRN rose 13.3% to $3.48 in pre-market trading after the company announced it will be offering a selection of meal kits without a subscription on Walmart.com.
- Revelation Biosciences, Inc. REVB rose 12.2% to $0.4944 in pre-market trading after dipping 16% on Wednesday.
- UiPath Inc. PATH shares rose 11% to $18.68 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q3 and FY23 sales guidance above analysts’ estimates.
- Burning Rock Biotech Limited BNR rose 10.2% to $2.60 in pre-market trading. Burning Rock received CE Mark for its OverC Multi-Cancer Detection Blood Test Kit.
- Verrica Pharmaceuticals Inc. VRCA rose 9.4% to $1.98 in pre-market trading after declining around 6% on Wednesday.
- BioXcel Therapeutics, Inc. BTAI rose 8.3% to $11.71 in pre-market trading after declining around 8% on Wednesday.
- Evofem Biosciences, Inc. EVFM rose 8.2% to $0.3749 in pre-market trading. Evofem Biosciences, last month, announced pricing of a roughly $26.6 million public offering.
- MongoDB, Inc. MDB rose 8% to $261.11 in pre-market trading after the company reported Q1 EPS results up from last year and better-than-expected sales results. The company also issued Q2 sales guidance above analysts’ estimates.
- Redbox Entertainment Inc. RDBX rose 7.2% to $6.02 in pre-market trading after declining over 16% on Wednesday.
Don’t forget to check out our premarket coverage here .
Losers
- C3.ai, Inc. AI shares fell 23.5% to $14.17 in pre-market trading after the company issued Q1 and FY23 sales guidance below analyst estimates.
- Histogen Inc. HSTO shares fell 19.9% to $0.1279 in pre-market trading. Histogen reported a 1-for-20 reverse stock split.
- Energy Focus, Inc. EFOI fell 13.9% to $1.05 in pre-market trading after jumping 37% on Wednesday.
- Agile Therapeutics, Inc. AGRX shares fell 12.4% to $1.20 in pre-market trading.
- ZW Data Action Technologies Inc. CNET shares fell 11.1% to $0.2888 in pre-market trading after dipping around 10% on Wednesday.
- Mullen Automotive, Inc. MULN fell 9.9% to $1.28 in pre-market trading. Mullen Automotive recently announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana.
- Zosano Pharma Corporation ZSAN fell 8.5% to $1.61 in pre-market trading. Zosano Pharma, last month, posted a Q1 loss of $7.86 per share.
- Meten Holding Group Ltd. METX fell 7.7% to $1.43 in pre-market trading.
- BHP Group Limited BHP fell 7.3% to $66.29 in pre-market trading after declining around 10% on Wednesday.
- Hewlett Packard Enterprise Company HPE fell 6.2% to $14.80 in pre-market trading after the company reported worse-than-expected Q2 financials results. The company also issued Q3 and FY22 EPS guidance with midpoints
below analyst estimates.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in